Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
IDEAYA Biosciences
Nurix Therapeutics, Inc.
Numab Therapeutics AG
Memorial Sloan Kettering Cancer Center
Checkpoint Therapeutics, Inc.
Mabpro, a.s.
Quadriga Biosciences, Inc.
Augusta University
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)